摘要
目的探讨真方白丸子汤治疗急性期脑梗死风痰入络型的疗效和对C-反应蛋白(CRP)的影响。方法对2013年6月至2015年9月治疗的94例急性期脑梗死患者进行随机分组,实验组应用真方白丸子汤治疗,对照组实施常规西医治疗,观察比较两组患者临床疗效、C-反应蛋白(CRP)、NIHSS评分、Barthel水平、住院时间和治疗费用差异。结果实验组治疗效果与对照组比较明显提高,CRP水平和NIHSS评分明显下降,Barthel水平提高,住院时间缩短,费用降低,差异有统计学意义(P<0.05)。结论针对急性期脑梗死风痰入络型患者采用真方白丸子汤治疗可提高治疗效果,改善CRP水平,缩短住院时间,降低住院费用,具有安全性高、疗效显著等特点,值得临床推广应用。
Objective To investigate the effect of Zhenfangbaiwanzi decoction on acute cerebral infarction wind phlegm into the network type and the impact on the CRP. Methods From June 2013 to September 2015, 94 patients with acute cerebral infarction were randomly divided into experiment group and the control group. The patients in the experiment group were given Zhenfangbaiwanzi decoction treatment, and the patients in the control group were given conventional western medicine treatment. The clinical effects, CRP, NIHSS, Barthel level, length of stay and cost of treatment differences were compared between the two groups. Results The treatment effect was significantly improved, CRP levels and NIHSS scores decreased significantly, and the level of Barthel increased, the hospital stays was shorter, the cost was lower, and the differences was significant (P 〈 0. 05). Conclusion In patients with cerebral infarction in acute stage of wind phlegm into meridian by Zhenfangbaiwanzi decoction treatment can improve therapeutic effect and to improve the levels of CRP, shorten the hospitalization time, reduce the hospitalization costs, has the characteristics of high safety and remarkable curative effect, which is worthy of clinical popularization and application.
出处
《临床医学》
CAS
2016年第9期116-117,共2页
Clinical Medicine
关键词
真方白丸子汤
急性期脑梗死
风痰入络型
C-反应蛋白
Zhenfangbaiwanzi decoction
Cerebral infarction
Wind phlegm into the network type
C-reactive protein